Pulmonary Disease in Patients Undergoing Hematopoietic Stem Cell Transplantation

February 24, 2017 updated by: Karen Wood

Pulmonary Disease in Patients Undergoing Hematopoietic Stem Cell Transplantation.

This will be a retrospective study and analysis of subjects who have undergone a hematopoietic stem transplant (either at OSUMC or external location) and were seen at OSUMC at any time between 01Jan2000 and 30Jun2011.

This study will determine factors influencing pulmonary disease and associated treatment strategies.

Study Overview

Status

Completed

Intervention / Treatment

Study Type

Observational

Enrollment (Actual)

200

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Ohio
      • Columbus, Ohio, United States, 43221
        • The Ohio State University Medical Center

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Sampling Method

Non-Probability Sample

Study Population

A patient record captured during 01Jan2000 and 30Jun2011 from the medical record at The Ohio State University Medical Center who were seen post hematopoietic stem transplant.

Description

Inclusion Criteria:

  • Adult patients who have undergone a hematopoietic stem transplant (either at OSUMC or external location) and were seen at OSUMC at any time between 01Jan2000 and 30Jun2011.
  • Age > 18 years

Exclusion Criteria:

  • Age <18 years
  • Prisoners

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
Post hematopoietic stem cell transplantation
Patients who were seen post hematopoietic stem cell transplantation between 01Jan2000 and 30Jun2011
Collection of data on patients who were seen at OSUMC at any time between 01Jan2000 and 30Jun2011 post hematopoietic stem cell transplantation

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
A retrospective diagnostic review on pulmonary disease related to hematopoietic stem cell transplantation.
Time Frame: Up to 15 years
To determine factors influencing pulmonary disease related to HSCT.
Up to 15 years

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
A retrospective treatment review on treatment strategies for pulmonary disease related to hematopoietic stem cell transplantation.
Time Frame: Up to 15 years
To review treatment strategies for pulmonary disease post transplant for effectiveness.
Up to 15 years

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

August 1, 2011

Primary Completion (Actual)

July 8, 2016

Study Completion (Actual)

July 8, 2016

Study Registration Dates

First Submitted

August 16, 2011

First Submitted That Met QC Criteria

August 17, 2011

First Posted (Estimate)

August 19, 2011

Study Record Updates

Last Update Posted (Actual)

February 27, 2017

Last Update Submitted That Met QC Criteria

February 24, 2017

Last Verified

October 1, 2015

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • 2011H0214

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Post Hematopoietic Stem Cell Transplantation

Clinical Trials on Data Collection

3
Subscribe